The Drosophila protocadherins Dachsous and Fat regulate growth and tissue polarity by modulating the levels, membrane localization and polarity of the atypical myosin Dachs. 
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Introduction
Precise coordination of growth and morphogenesis during development is critical for formation of organs of correct proportions and optimal function. This is achieved through the cumulative effect of biochemical signaling through morphogens and biomechanical signals mediated through the actomyosin network. The protocadherins Dachsous (Ds) and Fat initiate a signaling cascade (Fat signaling), which functions to restrict growth by activating the Hippo signaling pathway [1, 2] and influences morphogenesis by modulating planar cell polarity (PCP) [3] [4] [5] [6] . Fat signaling regulates the Hippo pathway and influences PCP by modulating membrane localization of the atypical myosin Dachs. Multiple studies have provided insight both into the mechanisms by which Dachs influences the Hippo pathway and PCP, and into how Fat regulates Dachs [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . However, the mechanisms that control Dachs levels and membrane localization are still not completely understood.
Ds and Fat are protocadherins with large extracellular domains (ECD) and small intracellular domains (ICD) and localize to the apico-lateral membrane just apical to the adherens junctions. The ECDs of Ds and Fat interact with each other across the cell-cell junctions in a heterophilic manner and the Golgi resident kinase, Four-jointed (Fj), modulates this interaction by phosphorylating their ECDs [19] [20] [21] [22] . In most developing tissues Ds and Fj are expressed in opposite gradients under the influence of morphogens [2] . The heterophilic interaction between Ds and Fat and the graded expression of Ds and Fj contributes to planar polarized localization of Ds and Fat within cells, where in the developing Drosophila wing Fat is preferentially enriched on the proximal side while Ds is enriched on the distal side [23] [24] [25] . Ds and Fat then regulate the levels and polarity of Dachs at cell membranes to influence Hippo signaling and PCP. In absence of Fat, increased amounts of Dachs accumulate around the entire circumference of cells [8, 24] . Conversely, overexpression of Fat or just the Fat ICD displaces Dachs from the membrane into the cytoplasm [8, 16] .
The Hippo signaling pathway plays a central role in growth regulation and includes Hippo and its cofactor Salvador and Warts (Wts) and the Warts cofactor Mats [26] . Hippo phosphorylates and activates Wts, which in turn phosphorylates the transcriptional co-activator Yorkie (Yki). Phosphorylated Yki is sequestered in the cytoplasm. When the pathway is inactive, unphosphorylated Yki translocates into the nucleus, where it associates with Scalloped and induces the transcription of downstream target genes such as expanded (ex), bantam (ban), and cyclin E, which modulate Hippo pathway activity, stimulate growth, and regulate cell fate. Multiple upstream regulators impinge on Wts to regulate Hippo signaling, including Fat signaling. Fat affects the membrane localization of Expanded, the levels of Wts and the interaction of Wts with Mats [7, 11, [27] [28] [29] [30] . Dachs is required for each of these effects on Hippo signaling. Similarly, Fat signaling influences PCP signaling partly by regulating the Spiny legs isoform of the prickle locus [12, 13] and partly through an influence on junctional tension [31] , and Dachs is involved in both of these processes.
Dachs localizes to the apico-lateral plasma membrane in a planar polarized manner [8] . In the developing wing discs Dachs localizes to the distal side of the cell [8, 23, 24, 32] . Several proteins that influence membrane localization of Dachs have been identified as components of the Fat signaling pathway. vamana (vam/Dlish) encodes an adapter protein with three SH3 domains that physically connects Dachs with the Fat and Ds ICDs, interacting with Dachs through its second SH3 domain and interacting with the Fat and Ds ICD through its first and third SH3 domains [14, 15] . Vam physically interacts with the C-terminal region of Dachs. Like Dachs, Vam localizes to the apical plasma membrane with preferential enrichment on the distal side of wing cells. In absence of Vam, Dachs fails to localize to the membrane and accumulates in the cytoplasm. Approximated encodes a palmitoyl transferase and is also required for Dachs membrane localization [33] . Although, the exact mechanism is still not clear, it can physically interact with both Dachs and Vam and can palmitoylate Vam and the Fat ICD when overexpressed [15, 34] .
Despite progress in our understanding of the Fat signaling pathway, how Dachs localizes to the apical membrane and how its levels at the membrane are regulated is still not completely understood. Here we report the isolation and characterization of the early girl (elgi) 
Results

elgi mutants display phenotypes similar to loss of fat
To identify contributions of protein stability to wing growth and patterning, we conducted a RNAi-based genetic screen, in which we depleted the RING domain E3 ubiquitin ligases encoded by the Drosophila genome within the wing pouch region of the developing wing imaginal disc using UAS RNAi lines and a nub-Gal4 driver. From this screen, we identified elgi, based on an increase in size of the adult wing, and a reduced spacing between the anterior and posterior cross veins when it is knocked down by either of two independent RNAi lines (Fig 1A-1E ). These phenotypes are hallmark features of mutations in components of the Fat signaling pathway [8, 14, 15, 33, [35] [36] [37] [38] [39] , suggesting that elgi could participate in Fat signaling.
elgi was previously characterized for a role in oogenesis, and named for a mutant phenotype including premature meiotic maturation [40] . Loss of function alleles that were isolated based on this oogenesis phenotype, elgi 1 and elgi
2
, also increase the size of adult wings and reduce spacing between the anterior and posterior cross veins when homozygous, or when hemizygous with a chromosomal deficiency that deletes the elgi locus (Fig 1F-1K) . elgi 1 mutant wing discs are also larger than control wing discs (Fig 1L and 1M ). These observations confirm that elgi regulates wing growth and patterning. Fat signaling regulates growth by controlling Hippo signaling. To examine the possibility that elgi regulates wing size through Hippo signaling, we depleted elgi in the posterior compartment of wing imaginal discs by expressing UAS-RNAi elgi under the control of en-gal4, and then examined the effect of this Elgi depletion on the levels of the Yki target genes ex and ban. Using ex-lacZ and ban-lacZ reporter genes, we observed that loss of elgi increased Yki activity (Fig 1N and 1O) , consistent with the inference that the increased wing size observed is due to impairment of Fat-Hippo signaling.
Elgi regulates Dachs and Vam levels
To further examine the possibility that Elgi could be involved in Ds-Fat signaling, and to begin to investigate how it might influence this pathway, we examined the effect of loss of elgi on the key Fat signaling components, Ds, Fat, Dachs and Vam. Depletion of elgi by RNAi did not result in any visible effect on the localization or levels of Ds (S2 Fig). Loss of elgi leads to a slight increase in Fat levels (Fig 2D) , but this cannot explain the increased Yki activity and wing growth observed, because over-expression of Fat decreases Yki activity and wing growth [7, 41] . In contrast, in cells lacking elgi, both Dachs and Vam, examined using genomic GFPtagged transgenes, accumulate at very high levels (Fig 2B and 2C, S4A Fig) . Since over-expression of Dachs or Vam can increase wing size [8, 14, 15] , this could potentially account for the increased wing growth associated with loss of elgi.
Absence of fat also leads to increased Dachs levels. To compare the increases in Dachs generated by loss of elgi versus loss of fat, elgi or fat were knocked down by RNAi in the posterior compartment of wing discs expressing Dachs:GFP, which were examined using the same imaging settings for both genotypes. This revealed that apical Dachs levels appear higher in the absence of elgi than in the absence of fat (Fig 2A and 2B) . However, in the absence of fat Dachs localizes evenly around the cell circumference at the sub-apical membrane, whereas in the absence of elgi Dachs localizes to the membrane in a punctate pattern, similar to its localization in wild-type cells.
To examine whether the increase in the levels of Dachs is transcriptional or post-transcriptional, we examined the influence of elgi-RNAi and elgi 1 mutant clones on a transgene expressing Dachs:GFP under the control of the Act5c promoter. Act5c-Dachs:GFP accumulated at high levels in the apical cortex in the absence of elgi (Fig 2E, S4C and S4E Fig) , just like Dachs: GFP expressed from its endogenous promoter, which indicates that elgi regulates Dachs at a post-transcriptional level. Consistent with this, western blotting of wing disc lysates revealed that loss of elgi leads to a significant increase in the levels of V5-tagged Dachs expressed ubiquitously under the control of a tub-Gal4 driver (Fig 2F) .
Elgi acts genetically upstream of Dachs, and in parallel to Fat
Mutation of upstream components of the Fat signaling pathway, including Fat, Ds, and Dco, increase Yki activity and wing growth by increasing levels of Dachs at the apical membrane [7, 8, 24] . To confirm that the increased Yki activity observed with elgi loss-of-function is due to increased Dachs, we investigated whether the elgi phenotype genetically depends upon dachs. Indeed, depletion of dachs by RNAi completely suppressed elevation of ex-lacZ expression by elgi RNAi, and wing disc cells with reduction of both proteins instead exhibit the loss of exlacZ expression characteristic of dachs RNAi (Fig 3A-3C) . Overexpression of Fat can displace Dachs from the membrane into the cytoplasm [8, 16] . To examine the genetic relationship between elgi and fat, we investigated the influence of elgi on this regulation of Dachs by Fat. Fat was overexpressed in the absence or in the presence of elgi RNAi in the posterior compartment of wing discs expressing Dachs:GFP. Overexpression of Fat caused a displacement of Dachs from the plasma membrane even in the presence of elgi RNAi (Fig 3E) . Thus, Fat over-expression is epistatic to elgi loss of function. Together with observations that elgi RNAi increases Fat levels, and that loss of Elgi or loss of Fat result in different patterns of increased Dachs, this suggests that fat and elgi function in parallel to regulate Dachs.
Normally Dachs localizes in a planar polarized manner, with a preferential localization to the distal side of wing disc cells [8] . To examine whether elgi affects Dachs polarity, we expressed Dachs:GFP in small clones in wing discs expressing elgi RNAi in the posterior compartment. While loss of elgi leads to an increase in the levels of Dachs:GFP, it is still mostly polarized to the distal side (Fig 3F) . Fat signaling regulates PCP as well as Hippo signaling, and loss of Fat results in Dachs-dependent disruption of hair polarity in the proximal wing [13, 42] . However, wings from elgi 1 mutant flies do not exhibit any defect in hair polarity (S1 Fig). These observations are consistent with the idea that the levels of membrane localized Dachs influence Hippo signaling, whereas the polarity of membrane Dachs influences PCP, and also further support the conclusion that Elgi and Fat act in parallel to regulate Dachs.
Elgi localizes to the cytoplasm and physically interacts with Dachs
To further investigate how Elgi regulates Dachs, we examined the localization of Elgi protein.
We created a GFP-tagged genomic copy of Elgi, but the extremely weak signal from this construct was insufficient to clearly establish its localization. Therefore we expressed a HA-tagged Early girl is a novel component of the Fat signaling pathway Elgi in the wing pouch under nub-Gal4 control. Overexpression of Elgi-Myc-HA under UASGal4 control results in a slightly smaller wing size (Fig 4D and 4F) , opposite to the effect of elgi loss-of-function, while also causing a very mild decrease in cross vein spacing (Fig 4C-4G ). This UAS-elgi-Myc-HA construct could rescue the reduced cross-vein spacing of an elgi Early girl is a novel component of the Fat signaling pathway These observations indicate that it has Elgi activity. Anti-HA antibody staining revealed a dispersed cytoplasmic localization for Elgi (Fig 4A) .
Fig 3. elgi regulates Dachs in parallel to Fat and does not affect Dachs polarity. (A-C) Third instar wing imaginal discs expressing en-Gal4 UAS-dcr2 UAS-GFP ex-lacZ and either UAS-elgi-RNAi (A, A') or UAS-dachs-RNAi (UAS-d-RNAi) (B, B') or UAS-elgi-RNAi and UAS-d-RNAi
elgi encodes for a predicted RING domain E3 ubiquitin ligase, homologous to vertebrate RNF41 protein. Since we found that Elgi regulates the levels of Dachs and Vam, we examined whether Elgi physically interacts with them. To test this, we co-expressed Myc-HA-epitopetagged Elgi along with V5-epitope-tagged full length Vam or Dachs, or N-terminal, middle or C-terminal fragments of Dachs, in S2 cells and conducted co-immunoprecipitation experiments. While Elgi does not interact with Vam, it can co-precipitate both full length Dachs, and the middle region of Dachs (Fig 4B) . Since Dachs can influence levels of Vam [14, 15] , this suggests that elgi could primarily affect Dachs, with the increase in Vam levels arising indirectly from the increase in Dachs levels. The middle region of Dachs is homologous to regions of myosin family proteins. Interestingly, a pulldown experiment identified Myo10A as an interactor of Elgi [43] , suggesting that Elgi interacts with a subset of myosin domains.
Since Elgi physically interacts with Dachs, influences Dachs levels, and encodes a predicted ubiquitin ligase, we examined whether it can ubiquitinate Dachs. We used a recently described method that employs biotinylated-Ubiquitin, as it is highly sensitive [44] . Briefly, when avitagged Ubiquitin fused to E.coli biotin ligase BirA (Bio-Ub) is expressed in cells, biotinylated Ubiquitin is produced, which is then incorporated by the ubiquitination machinery (Fig 5A) . We expressed Dachs:V5 in cultured Drosophila S2 cells along with Bio-Ub with or without Elgi, immunoprecipitated Dachs:V5 using a mouse anti-V5 antibody, and then immunoblotted with rabbit anti-V5 to detect Dachs:V5 and with fluorescently-conjugated streptavidin to detect biotinylated-Ubiquitin. As a positive control, we examined Elgi auto-ubiquitination, which was readily detected (Figs 5B and 6H). When Dachs was expressed along with Bio-Ub we detected a smear of biotinylated bands, both at higher molecular weight (presumably corresponding to poly-ubiquitinated Dachs) and at lower molecular weight (presumably corresponding to ubiquitinylated degradation products). When Elgi was co-expressed along with Dachs:V5 and Bio-Ub, this signal was not altered, aside from the detection of the co-immunoprecipitated Elgi band. These results suggest that Dachs is ubiquitinated by an E3 ligase present in S2 cells. However, because this signal does not change when Elgi is over-expressed, it appears that Elgi does not ubiquitinate Dachs. We also examined if Dachs ubiquitination in S2 cells depends upon Elgi. Using dsRNA, Elgi could be efficiently depleted in S2 cells (Fig 5D) . However, elgi RNAi did not decrease Dachs ubiquitination (Fig 5C) .
A catalytic mutant form of Elgi has as a neomorphic activity and interferes with App function
To evaluate the potential contribution of Elgi catalytic activity to Dachs regulation, we created a mutant version of elgi, elgi CS , in which the two cysteines (C18 and C21) in the highly conserved RING domain were mutated to serines. In other E3 ubiquitin ligases, this type of mutation has been reported to abolish catalytic activity [45, 46] . Consistent with this, while wild type Elgi can auto-ubiquitinate, Elgi CS lacks this activity (Fig 6H) . Over-expression of elgi CS results in a significant decrease in cross vein spacing in the adult wing, reminiscent of loss of elgi function (Fig 4E and 4G) . However, unlike loss of elgi, it does not lead to an increase in wing size (Fig 4E and 4F) . At the cellular level, expression of elgi CS resulted in a dramatic
UAS-elgi CS (E). Arrows point to the crossveins. (F-G)
Histograms of relative wing areas (normalized to the average wing area of control wings) (F) and ratios of CVD to wing length, (normalized to the average CVD to wing length ratio of control wings) (G) in flies of the genotypes in panels C-E, as indicated. Data are shown as mean ± SD from measurements of 12 wings per genotype.
� P<0.001, (Student's t test between control and the other genotypes).
https://doi.org/10.1371/journal.pgen.1007955.g004
Early girl is a novel component of the Fat signaling pathway (Fig 6B) , reminiscent of elgi RNAi, and opposite to the decrease in levels of Dachs observed when wild-type Elgi is over-expressed (Fig 6A) Fig, Fig 8A) bind to App and one of its identified substrates, the Fat-ICD (Fig 6J) . However, Elgi does not detectably promote their ubiquitination (Fig 5B and 5C Early girl is a novel component of the Fat signaling pathway 
(E-E") Horizontal apical sections of wing imaginal discs expressing nub-Gal4 UAS-dcr2 UAS-D:RFP UAS-Vam:GFP UASelgi-RNAi UAS-app-RNAi showing close up view of D:RFP (red) (E') and Vam-GFP (green) (E') colocalization. (F,G) Horizontal apical sections of wing imaginal discs expressing en-Gal4 UAS-elgi CS D:GFP (F) or along with UAS-app (G) showing the effect on
compartments. Alternatively, they could represent a transient vesicular trafficking structure that accumulates in the absence of Elgi and App. They could arise from coacervation. It is also possible that in absence of App and Elgi, Dachs accumulates in misfolded aggregates. Interestingly, palmitoylation is known to be required for the proper function of a number of chaperones [48, 49] , but it remains to be examined if App affects any chaperones. (Fig 7C and 7D) 
Elgi and App primarily affect Dachs rather than Vam
3xFLAG tagged Elgi or Elgi
CS were co-expressed with either BirA or BirA-BioUb and immunoprecipitated using anti-Flag beads. Elgi was detected by anti-FLAG antibody and biotinylated Ubiquitin was detected with IRDYE680 conjugated streptavidin (Red). (I) Western blot showing results of co-immunoprecipitation experiments on proteins co-expressed in S2 cells. V5-tagged Vam or Elgi were co-expressed with full length Elgi-3x-FLAG, and complexes were precipitated using anti FLAG affinity resin and immunoblotted with anti-V5 and anti-FLAG antibodies. GAPDH was used as a control for loading and transfer in the input lanes. Elgi-3x-FLAG has a slower mobility compared to Elgi-V5 due to the larger epitope tag. (J) Western blot showing results of co-immunoprecipitation experiments on proteins co-expressed in S2 cells. V5-tagged Vam, App (App-V5) or Fat-ICD (Fat-ICD-V5) were co-expressed with Elgi-3x-FLAG, and complexes were precipitated using anti-FLAG affinity resin and then immunoblotted with anti-V5 and anti-FLAG antibodies. GAPDH was used as a control for loading and transfer in the input lanes. Arrow points to the full length App in the input lane. 
Discussion
Our results identify the E3 ubiquitin ligase Elgi as playing a crucial role in modulating FatHippo signaling. Elgi regulates the stability of Dachs and, together with App, its membrane localization. Through its effects on Dachs, Elgi also indirectly regulates the levels and localization of Vam. Our observations suggest a model (Fig 8E) where, under normal conditions, Elgi expressed or when elgi and app are simultaneously depleted, the increased levels of Dachs and Vam are unable to localize to the membrane and instead accumulate in punctate structures in the cytoplasm. Due to the impact that membrane levels of Dachs have on Warts activity, Elgi influences the activity of Yki, the key transcription factor of the Hippo pathway.
Our observations indicate that Elgi regulates Dachs in parallel to Fat, and the distinct ways in which they regulate Dachs provide insight into how Dachs regulates Hippo signaling and PCP. The increase in Dachs at membranes appears greater when Elgi is knocked down than when Fat is knocked down but the increase in wing growth is greater when Fat is knocked down than when Elgi is knocked down. This might be explained by an influence of elgi on other proteins, which counteract the growth promoted by Dachs. Alternatively, it could be explained by the distinct patterns of Dachs membrane localization in fat versus elgi loss-offunction. In the absence of Fat, Dachs localizes to the membrane around the entire circumference of the cell, whereas in the absence of Elgi, Dachs still remains polarized. Investigations of Hippo signaling have revealed that Warts is activated in discrete complexes at the sub-apical membrane, where multiple upstream components co-localize [50, 51] . We suggest that when Dachs is membrane localized around the entire cell circumference, it is able to broadly disrupt Warts activation, whereas when Dachs is polarized, there could be regions of the sub-apical membrane where Warts activation can occur normally, resulting in a lower overall level of Yki activity than can be achieved with uniform Dachs membrane localization. The normal polarization of Dachs, together with the normal hair polarity in elgi mutants, is consistent with the conclusion that Fat signaling regulates PCP through the polarization of Dachs localization. Thus Elgi effectively separates the two distinct downstream branches of Fat signaling-it disrupts Hippo signaling, but leaves PCP unaffected.
Elgi is a homolog of mammalian RNF41/NRDP1, which regulates ErbB3 and ErbB4 receptors, BRUCE, BIRC6 and Parkin [52] [53] [54] . RNF41 also regulates trafficking of certain JAK2-associated type1 receptors [55] . Moreover, it can regulate PCP by ubiquitinating Dishevelled (DVL) [56] . Interestingly, RNF41 physically interacts with VANGL2 but does not ubiquitinate it [56] . Rather it ubiquitinates DVL, which is associated with VANGL2. RNF41 also stabilizes AP2S1 in an E3 ligase activity-independent manner [57] .
Although Elgi can physically interact with Dachs, App and Fat-ICD, we were unable to detect direct ubiquitination of these proteins by Elgi. Thus Elgi might regulate Dachs stability through an unknown protein. Alternatively, it is possible that Elgi might function as an adapter to facilitate proteosomal or endolysosomal degradation of Dachs. For example, Elgi might directly link Dachs (or a Dachs-Vam complex) to the proteasome. Some E3 ligases, such as Stuxnet, have been reported to regulate protein degradation without ubiquitination by acting in this way [58] . If Elgi plays a role in vesicular trafficking, it might not only promote trafficking of Dachs (or a Dachs-Vam complex) to the lysosome, it could also affect the localization and levels of other proteins. The increase in Fat levels in elgi mutant cells is consistent with this possibility.
Dachs is also regulated by FbxL7 [16, 17] , which like Elgi is predicted to be a ubiquitin ligase. It is also not clear if FbxL7 regulates Dachs by directly ubiquitinating it or instead by affecting vesicular trafficking. However, FbxL7 differs from Elgi in that FbxL7 regulates both direct proteosomal degradation of a Dachs/Vam complex. EE: early endosome, MVB: multi vesicular body, CRE: common recycling endosome, RE: recycling endosome, LE: late endosome. Scale bar is 16.5 μm in A-D.
https://doi.org/10.1371/journal.pgen.1007955.g008
Early girl is a novel component of the Fat signaling pathway the levels and the polarity of Dachs, and in that FbxL7 itself exhibits polarized membrane localization. The presence of multiple mechanisms to limit amounts of Dachs emphasize the importance of strict control over Dachs levels.
The palmitoyltransferase App is critical for membrane localization of Dachs [33] . Although App can palmitoylate Vam and the Fat ICD when overexpressed [15, 34] , the mechanism by which it regulates Dachs localization in vivo is still not clear. Our studies revealed that concomitant loss of Elgi and App leads to accumulation of Dachs and Vam in cytoplasmic punctae. The detection of these puncta might reflect a role for App in trafficking of Dachs and Vam. In the presence of wild-type Elgi, the low levels of Dachs could preclude detection of this trafficking defect, but the dramatic increase in Dachs levels in the absence of elgi could exacerbate accumulation of Dachs/Vam in vesicles and make them easier to detect. Consistent with this possibility, basal puncta of Dachs were detected when Elgi was depleted and Dachs was expressed using the act5C promoter. Alternatively, Elgi and App might impair distinct activities that are redundantly required for trafficking of Dachs and Vam. Palmitoylation is well known to play a key role in vesicular trafficking [59] . Further characterization of the nature of these cytoplasmic accumulations of Dachs could help understand the exact mechanism by which App regulates Dachs localization.
Our genetic experiments also suggest that Vam may not be a relevant substrate of App in vivo, as concomitant loss of vam and elgi does not result in the accumulations of Dachs observed in the absence of elgi and app. This is consistent with the finding that mutating a predicted palmitoylation site within Vam does not abrogate its membrane localization [14] . Our experiments also revealed that elgi and app primarily affect Dachs, and only indirectly affect Vam through its physical association with Dachs. This is consistent with the observation that 
Materials and methods
Drosophila strains
The following previously described alleles and transgenes were used, elgi 1 , elgi 2 [40] , Df(3L) 
GFP, UAS-vam-3x-FLAG-RFP, UAS-vam-ΔSH3-1-3x-FLAG-RFP, UASvam-ΔSH3-2-3x-FLAG-RFP, UAS-vam-ΔSH3-3-3x-FLAG-RFP and ACT>Stop>Vam-3x-FLAG-GFP [14], Jub:GFP [60], UAS-D:RFP, UAS-elgi RNAi (VDRC109617, NIG 17033R-3) UAS-Mito-GFP (BL8442), UAS-atg8a-GFP (52005), LAMP1-YFP (DGGR 115517), Rab4-YFP (BL62542), Rab5-YFP (BL62543), Rab7-YFP (BL62545), Rab11-YFP (BL62549). The transgenes UAS-elgi-Myc-HA and UAS-elgi
CS
-Myc-HA were created in this study.
Immunohistochemistry
Dissected wing discs were fixed in 4% paraformaldehyde for 10 minutes at room temperature and stained with primary antibodies, rat anti-E-cad (1:400, DSHB DCAD2), rat-anti-Fat GFP and RFP were detected by autofluorescence. Confocal images were captured using a Leica SP8 confocal microscope.
Molecular biology
To create pUAST-elgi-Myc-HA, elgi cDNA was PCR amplified with elgi-forward 5'TGAAT AGGGAATTGGGAATTCATGGGCTACGATGTGAATCGCTT3' and elgi-MYC-HA-rev CGCAAGATCTGTTAACGAATTCCTAAGCGTAATCTGGAACATCGTATGGGTACAGA TCCTCTTCTGAGATGAGTTTTTGTTCCTCGATGCCATGGGCGAAG3' primers and cloned into pUAST plasmid digested with EcoRI by Gibson assembly. To create pUASTelgi CS -Myc-HA, elgi cDNA was PCR amplified with elgi CS forward primer, 5'TGAATAGGGA ATTGGGAATTCATGGGCTACGATGTGAATCGCTTTCAGGGGGAGGTGGACGAGGA GCTCACCTCTCCCATCTCCTCCGGAGTGCTT 5' and elgi-MYC-HA-rev primer and cloned into pUAST plasmid digested with EcoRI by Gibson assembly. All plasmids were sequence verified. pUAST-elgi-V5 and pUAST-elgi-3xFLAG were similarly created using the elgi-forward primer and elgi-V5 reverse 5'GCAAGATCTGTTAACGAATTCCTAGGTGCTG TCCAGGCCCAGCAGGGGGTTGGGGATGGGCTTGCCCTCGATGCCATGGGCGAAG 3' and elgi-FLAG-reverse 5' GCAAGATCTGTTAACAATTCTTACTTGTCATCGTCATCCT TGTAATCGATGTCATGATCTTTATAATCACCGTCATGGTCTTTGTAGTCCTCGATG CCATGGGCGAAG primers respectively. pACU2-app:V5 was created by amplifying the app CDNA using forward 5'gttcaattacagctcgaattcATGAATCTGCTGTGCTGCTGTTG 3' and reverse primer 5' cgcagatctgttaacgaattcTTAGGTGCTGTCCAGGCCCAGCAGGGGGTTGG GGATGGGCTTGCCGACTATGGCCACGTTTGTGGTC and and cloned into pACU2 plasmid 
dsRNA production
Small fragments of elgi or EGFP coding sequences were selected using SnapDragon tool to avoid any off-target effect. For generating the template for dsRNA synthesis for elgi, elgi T7 forward 5'TAATACGACTCACTATAGGGGGATGCATTAACGAGTGGCTAACC 3' and T7 Reverse 5' TAATACGACTCACTATAGGGATAGTCAGCTGCTGGTCGGTG 3' primers were used. For dsRNA synthesis for EGFP, a fragment was amplified with the EGFP-T7 forward 5'TAATACGACTCACTATAGGGACGTAAACGGCCACAAGTTC 3' and EGFP-T7 reverse 5' TAATACGACTCACTATAGGGTGTTCTGCTGGTAGTGGTCG 3' primers. dsRNA synthesis was carried out using MEGAscript T7 transcription Kit (Invitrogen), following manufacturer's instruction. After synthesis the dsRNA was purified using RNAeasy mini Kit (Quiagen).
Cell culture, immunoprecipitation and western blotting
S2 cells were grown in Schneider's media and transfected with plasmids aw-GAL4, pUAST-D-:V5 [8] pUAST-D-N:V5, pUAST-D-M:V5, pUAST-D-C:V5 [10] , pUAST-Vam-V5 [14] along with pUAST-elgi-Myc-HA, using effectene transfection reagent (Quiagen) following the manufacturer's instruction. Cells were lysed in RIPA buffer supplemented with protease inhibitor cocktail and phosphatase inhibitor cocktail (Calbiochem). Cell lysates were incubated with affinity resin conjugated with anti HA antibody (Sigma) for two hours at 4˚C, following which they were washed four times. Proteins samples were boiled with Laemlii buffer and subjected to SDS-PAGE using 4-15% gradient gels (Bio Rad). Western transfer was carried out using Trans-Blot Turbo transfer system (Bio Rad) and immunoblotting was performed using the primary antibodies, rabbit-anti-V5 (Bethyl Laboratories, 1:5000), mouse anti-V5 (Invitrogen, 1:5000), mouse-anti-GAPDH (Covance, 1:1000), mouse anti α-Tubulin (1:20,000), mouse anti FLAG (Sigma, 1:5000) Rabbit anti FLAG (Sigma, 1:5000) and Guinea Pig anti App (gift from Seth Blair, 1:5000); and as secondary antibodies goat anti-mouse 680 (Li-Cor, 926-68,020), goat anti-rabbit-680 (Li-Cor, 926-68,021) and Donkey anti-Gunea Pig-780 (Li-Cor, 926-32411), all at a dilution of 1:10,000. Blots were scanned using an Odyssey Imaging System (Li-Cor). Co-immunoprecipitation experiments in Fig 6I and 6J were performed following similar protocols where S2 cells were transfected with aw-Gal4, pUAST-Elgi-3x-FLAG together with either pUAST-Vam-V5 or pUAST-Elgi-V5 (Fig 6I) or pACU2-App-V5 or pUAST-Fat-ICD-V5 (Fig 6J) . Elgi-3x-Flag was immunoprecipitated using EZ view Red FLAG M2 affinity Gel and immunoblotted with Mouse anti-FLAG and Rabbit-anti-V5 primary antibodies and donkey anti-mouse 680 and donkey antirabbit 780 secondary antibodies.
Ubiquitination assay
Ubiquitination assays were carried out as previously described [44] . Briefly, S2 cells were transfected with either pUAST-Vam:V5, pACU2-App:V5, pUAST-Fat-ICD:V5 or pUAST-D:V5 with or without pUAST-BioUb-BirA and pUAST-elgi-3x-FLAG along with pmt-Gal4. After incubation for 72 hours, protein expression was induced by adding 0.5mM CuSO 4 . In all ubiquitination experiments, to prevent degradation of the ubiquitinated products, cells were treated with the proteasome inhibitor MG132 (10uM) at the same time as CuSO 4 was added. After overnight incubation, cells were lysed in RIPA buffer supplemented with protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Calbiochem) and 10mM N-ethyl Maleimide (deubiquitinase inhibitor). Cell lysates were incubated with affinity resin conjugated with mouse anti-V5 antibody (Sigma) for two hours at 4˚C, following which they were washed four times. After washing, samples were boiled in Laemmli buffer and subjected to SDS-PAGE followed by Western transfer. Immunoblotting was performed using rabbit anti-FLAG and rabbit anti-V5 primary antibodies and goat anti-rabbit-800 (Licor) secondary antibody. IRDye-680RD-Streptavidin (Licor 925-68079) was used at 1:10000 dilution to detect biotin, and the blots were scanned using an Odyssey imaging system (LiCor). Elgi autoubiquitination was performed following a similar protocol, where S2 cells were transfected with pUAST-Elgi3x-Flag or pUAST-Elgi CS -3x-Flag along with pUAST-BirA or pUAST-BioUb-BirA and Elgi3x-Flag or Elgi CS -3x-Flag was immunoprecipitated using EZ view Red FLAG M2 affinity Gel (Sigma) and immunoblotted with Rabbit-anti-FLAG (Sigma) and above described secondary antibody and streptavidin. For RNAi, cells were resuspended in serum free Schneider's medium at a concentration of 1-4x10 5 cells/ml and to 1ml of of cell suspension, 30μg of either EGFP-shRNA or elgi-shRNA was added and incubated for 30 minutes, following which 1ml of fresh medium containing 20% serum was added. Immediately, they were transfected with either pUAST-Vam:V5, pACU2-App:V5, pUAST-Dachs:V5, or pUAST-Fat-ICD:V5 plasmid along with the pMT-Gal4 and pUAST-BirA-bioUB plasmids, using Effectene transfection reagent (Quiagen) following manufacturer's protocol. After incubation for 72 hours, protein expression was induced by adding 0.5mM CuSO 4 , in the presence of 10uM MG132. After overnight inductions the cells were collected and the proteins of interest were immunoprecipitated and processed as described above. Statistical analyses. Statistical significance was calculated using Graphpad Prism Software. For pairwise comparisons we used t test. 
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